ID24332A - Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus - Google Patents

Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus

Info

Publication number
ID24332A
ID24332A IDW991396A ID991396A ID24332A ID 24332 A ID24332 A ID 24332A ID W991396 A IDW991396 A ID W991396A ID 991396 A ID991396 A ID 991396A ID 24332 A ID24332 A ID 24332A
Authority
ID
Indonesia
Prior art keywords
composition
fine crystal
contains budesonide
budesonide particle
particle
Prior art date
Application number
IDW991396A
Other languages
English (en)
Indonesian (id)
Inventor
Mikael Bisrat
Saeed Moshashaee
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID24332A publication Critical patent/ID24332A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW991396A 1997-05-23 1998-05-15 Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus ID24332A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701956A SE9701956D0 (sv) 1997-05-23 1997-05-23 New composition of matter

Publications (1)

Publication Number Publication Date
ID24332A true ID24332A (id) 2000-07-13

Family

ID=20407079

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991396A ID24332A (id) 1997-05-23 1998-05-15 Komposisi yang mengandung partikel budesonida berbentuk kristal yang halus

Country Status (28)

Country Link
US (2) US6346523B1 (de)
EP (1) EP1005328B1 (de)
JP (1) JP2001525850A (de)
KR (1) KR100514971B1 (de)
CN (1) CN1146406C (de)
AR (1) AR015820A1 (de)
AT (1) ATE246492T1 (de)
AU (1) AU734763B2 (de)
BR (1) BR9808812A (de)
CA (1) CA2290538C (de)
DE (1) DE69816997T2 (de)
DK (1) DK1005328T3 (de)
EE (1) EE03850B1 (de)
ES (1) ES2205496T3 (de)
HU (1) HUP0002212A3 (de)
ID (1) ID24332A (de)
IL (1) IL133098A (de)
IS (1) IS5254A (de)
NO (1) NO995540L (de)
NZ (1) NZ500852A (de)
PL (1) PL336902A1 (de)
PT (1) PT1005328E (de)
SE (1) SE9701956D0 (de)
SK (1) SK158799A3 (de)
TR (1) TR199902880T2 (de)
TW (1) TW518236B (de)
WO (1) WO1998052544A1 (de)
ZA (1) ZA984127B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996025918A1 (en) * 1995-02-24 1996-08-29 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
RU2271851C2 (ru) 2000-03-03 2006-03-20 Бёрингер Ингельхайм Фармасьютиклз, Инк. Обработка материалов многократным расширением-сжатием растворителя
EP1354581A4 (de) * 2000-12-26 2007-07-04 Takeda Pharmaceutical Poröse substanz und verfahren zu ihrer herstellung
GB0106403D0 (en) * 2001-03-15 2001-05-02 Pharmaceutical Profiles Labelling of dry powder formulations for inhalation
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
JP2004537401A (ja) 2001-08-08 2004-12-16 ブラウン ユニバーシティ リサーチ ファウンデーション 疎水性薬物の微粉砕方法
DE60211004T2 (de) * 2001-10-10 2006-08-31 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Pulververarbeitung mit unter druck stehenden gasförmigen fluids
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
GB0216562D0 (en) * 2002-04-25 2002-08-28 Bradford Particle Design Ltd Particulate materials
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
JP2007501683A (ja) 2003-05-22 2007-02-01 エラン ファーマ インターナショナル リミテッド γ線照射によるナノ粒子活性物質分散体の滅菌法
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
ATE446581T1 (de) * 2004-03-12 2009-11-15 Trinity College Dublin Magnetoresistives medium
CN101312713A (zh) * 2005-03-18 2008-11-26 纳米材料科技有限公司 可吸入的药物
EP1904219A4 (de) 2005-07-15 2011-07-27 Map Pharmaceuticals Inc Teilchenbildungsverfahren
EP1782839A1 (de) 2005-11-03 2007-05-09 Genetic S.p.A. Verfahren zur Sterilisation von Glucocorticosteroiden mit überkritischem CO2
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070178051A1 (en) * 2006-01-27 2007-08-02 Elan Pharma International, Ltd. Sterilized nanoparticulate glucocorticosteroid formulations
WO2007095341A2 (en) * 2006-02-15 2007-08-23 Tika Läkemedel Ab Sterilization of corticosteroids with reduced mass loss
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US20100298602A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Systems and methods for microfluidic crystallization
US20100294986A1 (en) * 2009-05-19 2010-11-25 Massachusetts Institute Of Technology Supercritical fluid facilitated particle formation in microfluidic systems
EP2618816A4 (de) * 2010-09-22 2014-10-29 Map Pharmaceuticals Ltd Aerosol-zusammensetzung zur verabreichung von medikamenten
CN102975731B (zh) * 2012-04-24 2015-08-12 南车南京浦镇车辆有限公司 轨道车辆司机室骨架与车体的安装结构
WO2021219230A1 (en) 2020-04-30 2021-11-04 Paolo Fiorina Antiviral treatment
KR102567655B1 (ko) 2020-11-13 2023-08-17 주식회사 비츠로이엠 진공커패시터 및 진공커패시터 제조 방법
KR102739398B1 (ko) 2021-11-17 2024-12-06 주식회사 비츠로이엠 가변형 진공 커패시터
KR102739399B1 (ko) 2021-11-17 2024-12-06 주식회사 비츠로이엠 가변형 진공 커패시터의 나선형 전극 위치 결정구조

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1282405C (en) 1984-05-21 1991-04-02 Michael R. Violante Method for making uniformly sized particles from water-insoluble organic compounds
AU624421B2 (en) 1988-10-05 1992-06-11 Pharmacia & Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
GB9001635D0 (en) 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
DE69112917T2 (de) 1990-06-15 1996-05-15 Merck & Co Inc Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
SE9302777D0 (sv) 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
SG48301A1 (en) * 1991-12-18 1998-04-17 Astra Ab New combination
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
SE9501384D0 (sv) 1995-04-13 1995-04-13 Astra Ab Process for the preparation of respirable particles

Also Published As

Publication number Publication date
TR199902880T2 (xx) 2000-02-21
AR015820A1 (es) 2001-05-30
EP1005328A1 (de) 2000-06-07
BR9808812A (pt) 2000-07-18
DE69816997D1 (de) 2003-09-11
SK158799A3 (en) 2000-05-16
NZ500852A (en) 2001-07-27
IL133098A (en) 2005-03-20
ZA984127B (en) 1998-11-23
PT1005328E (pt) 2003-11-28
CA2290538C (en) 2007-01-02
US20020037257A1 (en) 2002-03-28
IS5254A (is) 1999-11-18
DE69816997T2 (de) 2004-07-22
TW518236B (en) 2003-01-21
ATE246492T1 (de) 2003-08-15
AU7680098A (en) 1998-12-11
EP1005328B1 (de) 2003-08-06
ES2205496T3 (es) 2004-05-01
SE9701956D0 (sv) 1997-05-23
DK1005328T3 (da) 2003-11-17
KR100514971B1 (ko) 2005-09-15
NO995540D0 (no) 1999-11-12
PL336902A1 (en) 2000-07-17
NO995540L (no) 1999-11-12
IL133098A0 (en) 2001-03-19
EE9900533A (et) 2000-06-15
EE03850B1 (et) 2002-10-15
CA2290538A1 (en) 1998-11-26
JP2001525850A (ja) 2001-12-11
HUP0002212A3 (en) 2001-04-28
CN1257424A (zh) 2000-06-21
US6468994B2 (en) 2002-10-22
HUP0002212A2 (hu) 2000-12-28
US6346523B1 (en) 2002-02-12
AU734763B2 (en) 2001-06-21
CN1146406C (zh) 2004-04-21
KR20010012821A (ko) 2001-02-26
WO1998052544A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
GB2291266B (en) Improvements in or relating to the formation of semiconductor devices
SG55368A1 (en) Abrasive composition and use of the same
DK1005328T3 (da) Sammensætning omfattende findelte krystallinske partikler af budesonid
ID26022A (id) Bentuk galenic pelepasan yang telah diperpanjang dan pelepasan lanjutan yang terdiri dari bahan peningkat absorpsi yang dapat diberikan melalui mulut dan penggunaan bahan peningkat absorpsi tersebut
DE69932552D1 (de) Pulver-Zusammensetzung und kosmetische Zusammensetzung enthaltend dieselbe
ZA985874B (en) New scleroglucans and cosmetic compositions containing the new compounds
GB2334718B (en) Phenylacetylene compound and liquid crystal composition comprising the same
PL341820A1 (en) Coating composition in the form of dry powder
IL114229A (en) Compositions for applying active substances to or through the skin
AU1398399A (en) The use of particles in the composition of cosmetic products
FI970607A7 (fi) Parannuksia materiaalin levityksessä alustaan
ZA985206B (en) Binder compositions use thereof and a process for the manufacture of particle board
FI956324A7 (fi) Organofunktionaalisten polysiloksaanien käyttö hienojakoisten hiukkasten pintojen modifioimiseksi
AU4057197A (en) Composition to aid in the forming of metal
GB0115657D0 (en) High quality surface engineering of domain structures in congruent lithium niobate single crystals
AU1238900A (en) Speckle particles and compositions containing the speckle particles
AU2554595A (en) Compositions and uses thereof in the diagnosis of psoriasis
GB9319018D0 (en) Improvements relating to the application of materials to ground surfaces
GB2286286B (en) Improvements in or relating to the fabrication of semiconductor devices
GB9800847D0 (en) Improvements in or relating to the manufacture of cellulosic particles
GB2340937B (en) Improvements relating to the measurement of particle size distribution
FR2736833B1 (fr) Composition super-absorbante et pansement contenant cette composition
ID24341A (id) Komposisi-komposisi pestisida lepas yang dapat dikontrol
EG21473A (en) Method and circula instrument to grind or mix materials by vibration or grind and mix at the same time
Baars Are There Limits to What We Can Know about Conscious Experience? Some Scientific Doubts about the" Hard Problem" of Subjectivity